莎普爱思品牌怎么样 申请店铺

我要投票 莎普爱思在滴眼液行业中的票数:398 更新时间:2025-07-15
莎普爱思是哪个国家的品牌?「莎普爱思」是 浙江莎普爱思药业股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人陈德康在2000-07-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力莎普爱思品牌出海!将品牌入驻外推网,定制莎普爱思品牌推广信息,可以显著提高莎普爱思产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

莎普爱思怎么样

公司自1978年建厂以来,经历了从“国营浙江平湖制药厂”转制成“浙江平湖制药厂(股份合作)”到“浙江平湖莎普爱思制药有限公司”,再到“浙江莎普爱思制药有限公司”,最终于2008年12月15日更名为“浙江莎普爱思药业股份有限公司”,目前注册资金为4900万元人民币。

公司作为一家专业从事药品研发、生产、经营的综合性制药企业,先后被列为“国家高新技术企业”、“浙江省百家最具投资价值企业”、“浙江省千家成长之星企业”、“浙江省级企业技术中心”、“省级高新技术研究开发中心”、“浙江省标准创新型企业”、“嘉兴市重点企业技术创新团队”、“院士专家工作站”等多项荣誉称号。

目前公司拥有大容量注射剂(玻璃瓶、塑料瓶和多层共挤膜袋)、口服溶液剂、滴眼剂、片剂(含头孢菌素类)、硬胶囊剂(含头孢菌素类)、栓剂、颗粒剂(含头孢菌素类)、干混悬剂(含头孢菌素类)、冲洗剂共10个剂型,近百种规格的产品批准文号。抗白内障新药“莎普爱思”滴眼液和抗青光眼新药“达靓”滴眼液被列入“国家火炬计划项目”。“莎普爱思”滴眼液还荣获国家重点科技攻关项目、国家重点新产品、浙江省名牌产品等多个称号,是国内第一个国家二类眼科专科新药。

几十年来,公司凭着优质的产品,良好的信誉,在市场竞争日益激烈的情况下,赢得了市场,产品销往全国各地,取得了良好的经济效益。近年来公司的产品销量与销售额都呈现出逐年增涨的态势,是平湖市重点扶持的股改上市企业。

在竞争激烈的医药市场中,我公司始终坚持科技兴业、加强管理、保证质量,不断推出各种自主研发的新产品。公司秉承“科技创新、求是进取、优质高效、和谐健康”的企业精神,不断寻求创新与突破,逐步使公司成为现代化、高科技制药企业。

莎普爱思的未来将坚持以市场为导向,发展为主题,科技创新为核心。以保护和增进人民健康、提高人民福祉为目标。我们确信莎普爱思的无限“关爱”会遍及中国,走向世界。

Since its establishment in 1978, the company has gone through the transformation from "state-owned Zhejiang Pinghu pharmaceutical factory" to "Zhejiang Pinghu pharmaceutical factory (joint stock cooperation)" to "Zhejiang Pinghu sapais Pharmaceutical Co., Ltd." and then to "Zhejiang sapais Pharmaceutical Co., Ltd." and finally changed its name to "Zhejiang sapais pharmaceutical Co., Ltd." on December 15, 2008, with the current registered capital of 49 million yuan RMB. As a comprehensive pharmaceutical enterprise specializing in drug R & D, production and operation, the company has been listed as "national high-tech enterprise", "one hundred enterprises with the most investment value in Zhejiang Province", "one thousand growth star enterprises in Zhejiang Province", "Zhejiang provincial enterprise technology center", "provincial high-tech research and development center", "Zhejiang standard innovation enterprise" "Jiaxing key enterprise technology innovation team", "academician expert workstation" and other honorary titles. At present, the company has 10 dosage forms of large capacity injection (glass bottles, plastic bottles and multi-layer coextrusion film bags), oral solution, eye drops, tablets (including cephalosporins), hard capsules (including cephalosporins), suppositories, granules (including cephalosporins), dry suspension (including cephalosporins), washing agents, and approval numbers of nearly 100 specifications of products. The new anti cataract drug "sapais" eye drops and the new anti glaucoma drug "Daliang" eye drops are listed in the "National Torch Program project". "Saps eye drops" also won the titles of national key scientific and technological research projects, national key new products, Zhejiang famous brand products, etc., and is the first national class II ophthalmic specialty new drug in China. In the past few decades, with its high quality products and good reputation, the company has won the market and sold its products to all parts of the country under the increasingly fierce market competition, and achieved good economic benefits. In recent years, the sales volume and sales volume of the company have been increasing year by year. It is a listed company supported by Pinghu City. In the highly competitive pharmaceutical market, our company always adheres to the development of science and technology, strengthening management, ensuring quality, and constantly launches various new products independently researched and developed. The company adheres to the enterprise spirit of "scientific and technological innovation, truth-seeking and enterprising, high-quality and efficient, harmonious and healthy", constantly seeks innovation and breakthrough, and gradually makes the company become a modern, high-tech pharmaceutical enterprise. In the future, SAPS will adhere to the market-oriented, development oriented theme and technological innovation as the core. With the goal of protecting and promoting people's health and improving people's well-being. We are sure that the infinite "love" of sapeus will spread all over China and go to the world.

本文链接: https://brand.waitui.com/a5a71ec58.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

德国央行:2025年该国经济或持续面临零增长困境

当地时间14日,德国央行在其月度报告中披露,德国经济在全球市场的竞争力正在流失。报告指出,“自2017年起,德国出口所占的市场份额便持续下滑。”出口市场的疲软态势,明显加剧了德国经济当前所面临的危机。照此趋势发展,到2025年,德国经济极有可能连续第三年陷入零增长的困境。(央视新闻)

37分钟前

美股大型科技股盘前涨跌不一,特斯拉涨超1%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,特斯拉涨超1%,奈飞涨0.52%,英伟达涨0.31%,亚马逊涨0.06%;苹果跌0.79%,微软跌0.4%,Meta跌0.17%,谷歌跌0.12%。

37分钟前

媒体:巴西议员计划赴美讨论关税问题

巴西议员将于9月赴美与美国官员讨论唐纳德·特朗普宣布的关税措施,CNN Brasil援引参议院外交关系委员会主席的话报道。据报道,尽管公布这一计划行程日期,但部分议员正努力将访问时间提前至7月。四名议员将参加此次访问。(新浪财经)

37分钟前

考拉悠然推出悠然无界大模型

36氪获悉,考拉悠然推出悠然无界大模型(Uran Boundless),该模型采用轻量化参数架构,构建出首个面向工业级场景的空间智能闭环系统。其7B与32B版本在多模态理解、物理常识推理、具身执行等任务中刷新多项SOTA记录,部分能力超越GPT-4o、Gemini 2.5等国际模型及Qwen等开源模型。

38分钟前

热门中概股美股盘前多数上涨,蔚来涨超5%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,蔚来涨超5%,理想汽车涨超2%,阿里巴巴、哔哩哔哩涨超1%,小鹏汽车涨0.75%,京东涨0.29%,拼多多涨0.23%,百度跌超1%。

38分钟前

本页详细列出关于莎普爱思的品牌信息,含品牌所属公司介绍,莎普爱思所处行业的品牌地位及优势。
咨询